August 15th, 2017
Several drugmakers – including AstraZeneca, Pfizer, Procter & Gamble, and Takeda – are facing lawsuits over complications linked to a …
Tags: AstraZeneca, chronic kidney disease, GERD, kidney damage, liver failure, MDL, Nexium, Pfizer, PPI, Prevacid, Prilosec, Procter & Gamble, proton pump inhibitors, Protonix, Takeda
Posted in HO&P Legal Blog, Proton Pump Inhibitors PPIs |
January 27th, 2016
Executives with Takeda Pharmaceutical, the manufacturer of Actos, admitted that they had paid physicians to prescribe the drug to patients …
Tags: Actos, bladder cancer, diebetes, False Claims Act, FDA, kickbacks, pre-diabetes, qui tam, Takeda, whistleblowers
Posted in Actos, HO&P Legal Blog, Qui Tam Litigation |
August 31st, 2015
A new study published by the Journal of the American Medical Association (JAMA) has found that the diabetes drug Actos …
Tags: Actos, bladder cancer, diabetes, pancreatic cancer, prostate cancer, Takeda
Posted in Actos, HO&P Legal Blog |
July 20th, 2015
Takeda Pharmaceuticals has agreed to pay $2.4 billion to settle thousands of lawsuits filed by patients who developed bladder cancer …
Tags: Actos, bladder cancer, FDA, MDL, Takeda
Posted in Actos, HO&P Legal Blog |
October 7th, 2014
A proposed class action regarding the drug Actos will be part of a larger multidistrict litigation (MDL) taking place in …
Tags: Actos, class action, Eli Lilly, MDL, Multidistrict Litigation, Takeda
Posted in Actos, Class Action Lawsuits, HO&P Legal Blog, Multidistrict Litigation |